ArticleACS omega2025
Linear Support Vector Machine Model of an IR Spectral Library: Application to Skin Cancer.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ex Vivo Assessment of Keratinocytic Carcinomas Using a Fast Mid-Infrared Probe.Journal of biophotonics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The primary result of this work is the derivation and measurement of the average "Decision Contribution Spectrum" using a mouse tumor sample data set and the linear support vector machine (SVM) method from a perspective of spectroscopy. The "Decision Contribution Spectrum" gives the average contribution to the decision (tumor/nontumor in this case) at each step along the spectrum. A library of more than four thousand infrared (IR) spectra was obtained with a Fourier Transform Infrared (FTIR) microscope imaging system on a frozen section of an SKH1 mouse tumor - an accepted murine model for studying squamous cell carcinoma in that it very closely recapitulates the human disease. A linear SVM model was trained and tested avoiding overtraining and offering simple feature selection. It was used to see how much data can be removed without affecting the quality of decisions. Then, two further efforts are described to move IR spectroscopy toward future use in human skin cancer detection: (i) the design of a reduced range and reduced sampling for a fast and hand-held, mid-infrared spectral probe, and (ii) the use of a fiber-loop sensor probe (with FTIR in this preliminary study) on live SKH1 mice that had tumors to detect cancer externally and show no ill effects on the mice. The combination of the latter efforts supports the feasibility of using a fiber-loop sensor with a fast and hand-held mid-infrared spectral probe for the detection of skin cancer on humans. This work does not demonstrate a working human skin cancer probe, rather it provides evidence for judging whether work on live human skin is justified.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.